These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 18350273)
1. Moderate and severe traumatic brain injury induce early overexpression of systemic and brain gelatinases. Vilalta A; Sahuquillo J; Rosell A; Poca MA; Riveiro M; Montaner J Intensive Care Med; 2008 Aug; 34(8):1384-92. PubMed ID: 18350273 [TBL] [Abstract][Full Text] [Related]
2. Early Gelatinase Activity Is Not a Determinant of Long-Term Recovery after Traumatic Brain Injury in the Immature Mouse. Semple BD; Noble-Haeusslein LJ; Gooyit M; Tercovich KG; Peng Z; Nguyen TT; Schroeder VA; Suckow MA; Chang M; Raber J; Trivedi A PLoS One; 2015; 10(11):e0143386. PubMed ID: 26588471 [TBL] [Abstract][Full Text] [Related]
3. Elevation of matrix metalloproteinases 3 and 9 in cerebrospinal fluid and blood in patients with severe traumatic brain injury. Grossetete M; Phelps J; Arko L; Yonas H; Rosenberg GA Neurosurgery; 2009 Oct; 65(4):702-8. PubMed ID: 19834375 [TBL] [Abstract][Full Text] [Related]
5. Association between the cerebral inflammatory and matrix metalloproteinase responses after severe traumatic brain injury in humans. Roberts DJ; Jenne CN; Léger C; Kramer AH; Gallagher CN; Todd S; Parney IF; Doig CJ; Yong VW; Kubes P; Zygun DA J Neurotrauma; 2013 Oct; 30(20):1727-36. PubMed ID: 23799281 [TBL] [Abstract][Full Text] [Related]
6. Matrix metalloproteinase-9 expression and protein levels after fluid percussion injury in rats: the effect of injury severity and brain temperature. Jia F; Pan YH; Mao Q; Liang YM; Jiang JY J Neurotrauma; 2010 Jun; 27(6):1059-68. PubMed ID: 20233042 [TBL] [Abstract][Full Text] [Related]
7. A prospective evaluation of the temporal matrix metalloproteinase response after severe traumatic brain injury in humans. Roberts DJ; Jenne CN; Léger C; Kramer AH; Gallagher CN; Todd S; Parney IF; Doig CJ; Yong VW; Kubes P; Zygun DA J Neurotrauma; 2013 Oct; 30(20):1717-26. PubMed ID: 23725031 [TBL] [Abstract][Full Text] [Related]
8. Matrix metalloproteinase 9 and cellular fibronectin plasma concentrations are predictors of the composite endpoint of length of stay and death in the intensive care unit after severe traumatic brain injury. Copin JC; Rebetez MM; Turck N; Robin X; Sanchez JC; Schaller K; Gasche Y; Walder B Scand J Trauma Resusc Emerg Med; 2012 Dec; 20():83. PubMed ID: 23249478 [TBL] [Abstract][Full Text] [Related]
9. Matrix metalloproteinases and their tissue inhibitors in serum and cerebrospinal fluid of patients with moderate and severe traumatic brain injury. Zheng K; Li C; Shan X; Liu H; Fan W; Wang Z; Zheng P Neurol India; 2013; 61(6):606-9. PubMed ID: 24441327 [TBL] [Abstract][Full Text] [Related]
10. Increased matrix metalloproteinase-9 in blood in association with activation of interleukin-6 after traumatic brain injury: influence of hypothermic therapy. Suehiro E; Fujisawa H; Akimura T; Ishihara H; Kajiwara K; Kato S; Fujii M; Yamashita S; Maekawa T; Suzuki M J Neurotrauma; 2004 Dec; 21(12):1706-11. PubMed ID: 15684762 [TBL] [Abstract][Full Text] [Related]
11. Plasma matrix metalloproteinase-9 levels predict intensive care unit mortality early after severe traumatic brain injury. Simon D; Evaldt J; Nabinger DD; Fontana MF; Klein MG; do Amaral Gomes J; Regner A Brain Inj; 2017; 31(3):390-395. PubMed ID: 28156136 [TBL] [Abstract][Full Text] [Related]
12. Influence of therapeutic hypothermia on matrix metalloproteinase activity after traumatic brain injury in rats. Truettner JS; Alonso OF; Dietrich WD J Cereb Blood Flow Metab; 2005 Nov; 25(11):1505-16. PubMed ID: 15959464 [TBL] [Abstract][Full Text] [Related]
13. Blood-brain barrier permeability is positively correlated with cerebral microvascular perfusion in the early fluid percussion-injured brain of the rat. Lin Y; Pan Y; Wang M; Huang X; Yin Y; Wang Y; Jia F; Xiong W; Zhang N; Jiang JY Lab Invest; 2012 Nov; 92(11):1623-34. PubMed ID: 22964852 [TBL] [Abstract][Full Text] [Related]
14. The prognostic value of brain extracellular fluid nitric oxide metabolites after traumatic brain injury. Tisdall MM; Rejdak K; Kitchen ND; Smith M; Petzold A Neurocrit Care; 2013 Aug; 19(1):65-8. PubMed ID: 22002154 [TBL] [Abstract][Full Text] [Related]
15. Prognostic utility of early plasma matrix metalloproteinases -2 and -9 concentrations after severe traumatic brain injury. Lima R; Simon D; Silva WDLD; Nabinger DD; Regner A Rev Bras Ter Intensiva; 2020; 32(3):418-425. PubMed ID: 33053032 [TBL] [Abstract][Full Text] [Related]
16. Moderate and severe traumatic brain injury: effect of blood alcohol concentration on Glasgow Coma Scale score and relation to computed tomography findings. Rundhaug NP; Moen KG; Skandsen T; Schirmer-Mikalsen K; Lund SB; Hara S; Vik A J Neurosurg; 2015 Jan; 122(1):211-8. PubMed ID: 25361494 [TBL] [Abstract][Full Text] [Related]
17. Effect of acute poly(ADP-ribose) polymerase inhibition by 3-AB on blood-brain barrier permeability and edema formation after focal traumatic brain injury in rats. Lescot T; Fulla-Oller L; Palmier B; Po C; Beziaud T; Puybasset L; Plotkine M; Gillet B; Meric P; Marchand-Leroux C J Neurotrauma; 2010 Jun; 27(6):1069-79. PubMed ID: 20380552 [TBL] [Abstract][Full Text] [Related]
18. Detection of neurofilament-H in serum as a diagnostic tool to predict injury severity in patients who have suffered mild traumatic brain injury. Gatson JW; Barillas J; Hynan LS; Diaz-Arrastia R; Wolf SE; Minei JP J Neurosurg; 2014 Nov; 121(5):1232-8. PubMed ID: 25192482 [TBL] [Abstract][Full Text] [Related]
19. Synthetic gelatinases inhibitor attenuates electromagnetic pulse-induced blood-brain barrier disruption by inhibiting gelatinases-mediated ZO-1 degradation in rats. Qiu LB; Zhou Y; Wang Q; Yang LL; Liu HQ; Xu SL; Qi YH; Ding GR; Guo GZ Toxicology; 2011 Jul; 285(1-2):31-8. PubMed ID: 21501651 [TBL] [Abstract][Full Text] [Related]
20. Persistently high circulating tissue inhibitor of matrix metalloproteinase-1 levels in non-survivor brain trauma injury patients. Lorente L; Martín MM; Ramos L; Argueso M; Cáceres JJ; Solé-Violán J; Jiménez A; Borreguero-León JM; González-Rivero AF; Orbe J; Rodríguez JA; Páramo JA J Crit Care; 2019 Jun; 51():117-121. PubMed ID: 30802757 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]